Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Equities researchers at KeyCorp issued their Q1 2018 earnings estimates for Allscripts Healthcare Solutions in a research note issued to investors on Tuesday, according to Zacks Investment Research. KeyCorp analyst D. Hooker expects that the software maker will earn $0.13 per share for the quarter. KeyCorp currently has a “Hold” rating on the stock. KeyCorp also issued estimates for Allscripts Healthcare Solutions’ Q2 2018 earnings at $0.13 EPS, Q3 2018 earnings at $0.13 EPS and Q4 2018 earnings at $0.16 EPS.
Several other equities analysts have also issued reports on the company. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. Maxim Group reiterated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. Robert W. Baird lifted their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, November 3rd. Finally, Dougherty & Co reiterated a “buy” rating and issued a $16.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a report on Tuesday, October 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have issued a buy rating to the stock. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and an average target price of $15.06.
TRADEMARK VIOLATION NOTICE: “Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Expected to Post Q1 2018 Earnings of $0.13 Per Share” was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/11/13/allscripts-healthcare-solutions-inc-mdrx-forecasted-to-earn-q1-2018-earnings-of-0-13-per-share.html.
Allscripts Healthcare Solutions (NASDAQ MDRX) traded down $0.09 on Friday, hitting $12.57. The stock had a trading volume of 1,372,500 shares, compared to its average volume of 1,884,943. The company has a current ratio of 0.98, a quick ratio of 0.93 and a debt-to-equity ratio of 1.20. The stock has a market cap of $2,271.16, a price-to-earnings ratio of 29.23, a PEG ratio of 2.24 and a beta of 1.35. Allscripts Healthcare Solutions has a 12-month low of $9.96 and a 12-month high of $14.45.
In related news, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $67,600.00. Following the completion of the transaction, the executive vice president now directly owns 196,607 shares in the company, valued at approximately $2,658,126.64. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $202,800.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,000 shares of company stock valued at $473,800. 0.75% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of MDRX. UBS Asset Management Americas Inc. lifted its holdings in Allscripts Healthcare Solutions by 31.6% in the 1st quarter. UBS Asset Management Americas Inc. now owns 129,106 shares of the software maker’s stock worth $1,637,000 after purchasing an additional 30,966 shares in the last quarter. Karp Capital Management Corp purchased a new position in Allscripts Healthcare Solutions in the 1st quarter worth approximately $205,000. Prudential Financial Inc. lifted its holdings in Allscripts Healthcare Solutions by 5.6% in the 1st quarter. Prudential Financial Inc. now owns 111,917 shares of the software maker’s stock worth $1,419,000 after purchasing an additional 5,960 shares in the last quarter. Credit Agricole S A purchased a new position in Allscripts Healthcare Solutions in the 1st quarter worth approximately $300,000. Finally, OppenheimerFunds Inc. lifted its holdings in Allscripts Healthcare Solutions by 9.4% in the 1st quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock worth $399,000 after purchasing an additional 2,701 shares in the last quarter.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.